Canine Valley Fever: Welfare and Long-Term Management in Endemic Areas

Valley fever (coccidioidomycosis) is a serious fungal disease affecting dogs in southwestern US and Latin American arid regions, causing prolonged illness requiring long-term antifungal treatment.

Key Facts

Valley fever is caused by Coccidioides immitis and C. posadasii fungi in desert soils
Dogs acquire infection by inhaling spores during soil disturbance in endemic areas
Clinical signs include cough, fever, weight loss, and lameness from bone infection
Disseminated disease affects bones, eyes, skin, brain, and multiple organs
Long-term fluconazole or itraconazole treatment for months to years is required

Welfare Considerations

Valley fever causes prolonged systemic illness with significant welfare compromise through chronic respiratory disease, bone pain from osteomyelitis, and the metabolic burden of disseminated fungal infection. The requirement for long-term antifungal treatment — sometimes lifelong — creates ongoing medication burden and monitoring requirements. Dogs with disseminated disease may experience months of significant welfare compromise before treatment achieves adequate disease control. Early diagnosis and prompt antifungal therapy prevents the most severe dissemination, making regular veterinary assessment in endemic areas an important welfare safeguard for dogs living in southwestern US desert regions.

What You Can Do

Seek veterinary assessment promptly for dogs in endemic areas showing cough and lethargy
Request Coccidioides serology testing when valley fever is clinically suspected
Follow long-term antifungal treatment protocols and attend monitoring appointments
Avoid exposing dogs to disturbed desert soil and dusty construction sites in endemic areas
Monitor for disease dissemination including lameness, eye changes, and neurological signs